Eldan announced new partnership with Ultivue in Israel!
Ultivue is an innovative reagent-based solution that maximizes the biological information available from cells and tissue samples.
Ultivue’s technology is being used to elucidate biological pathways and validate clinically-relevant biomarkers and provides researchers and scientists with multiplex biomarker assays, for tissue phenotyping and digital pathology.
Ultivue’s proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research.
Please contact Eldan’s Bio-Team for details.